Publicacións en colaboración con investigadores/as de Hospital do Meixoeiro (9)

2014

  1. Final results of a phase II study of paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer

    Clinical and Translational Oncology, Vol. 17, Núm. 2, pp. 160-166

  2. Full-dose cisplatin and oral vinorelbine concomitant with radiotherapy in unresectable stage III non-small cell lung cancer: A multi-center phase II study

    Anticancer Research, Vol. 34, Núm. 4, pp. 1959-1966

2009

  1. A phase II randomized trial of gemcitabine-docetaxel versus gemcitabine-cisplatin in patients with advanced non-small cell lung carcinoma

    Cancer Chemotherapy and Pharmacology, Vol. 64, Núm. 2, pp. 379-384

2007

  1. Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer: A lung cancer Galician group phase II study

    Cancer Chemotherapy and Pharmacology, Vol. 60, Núm. 5, pp. 725-732

2004

  1. Docetaxel plus epirubicin is a highly active, well-tolerated, first-line chemotherapy for metastatic breast cancer: Results of a large, multicentre phase II study

    Cancer Chemotherapy and Pharmacology, Vol. 53, Núm. 1, pp. 75-81

2003

  1. Gemcitabine, cisplatin and vinorelbine as induction chemotherapy followed by radical therapy in stage III non-small-cell lung cancer: A multicentre study of galician-lung-cancer-group

    Lung Cancer, Vol. 40, Núm. 2, pp. 215-220

1998

  1. Carcinoma microcitico extrapulmonar. Analisis de seis casos

    Oncologia, Vol. 21, Núm. 7, pp. 54-57

  2. Metastasis de leiomiosarcoma uterino en oido medio (hueso temporal). A proposito de un caso

    Oncologia, Vol. 21, Núm. 6, pp. 57-61

1992

  1. CARCINOMA DE VEJIGA EN ASOCIACION CON CLICOFOSFAMIDA: A PROPOSITO DE UN CASO Y REVISION DE LA LITERATURA

    Revista Espanola de Geriatria y Gerontologia, Vol. 27, Núm. 3, pp. 171-173